Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Alliance Entertainment Holding Corporation announced its participation in two prominent investor conferences in New York City in October 2026, with key executives presenting company updates and discussing trends in entertainment commerce and retail.
Ultragenyx Pharmaceutical announced a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $210 million. The PRV was granted following FDA approval of Genelycos™, a treatment for glycogen storage disease type Ia. The sale is expected to provide non-dilutive capital to advance Ultragenyx's pipeline and support pr…
Achieve Life Sciences has appointed Kaitlyn Tuson as Senior Vice President of Marketing and Communications to lead the company's brand strategy and marketing efforts as it prepares for the possible commercialization of cytisinicline, a plant-based treatment for nicotine dependence. This appointment follows key strategic moves in 2026 including a CE…
Beeline Holdings, Inc., a digital mortgage platform, announced it will host a stakeholder call to discuss its Q3 2026 financial results on November 12, 2026. The call will be led by CEO Nick Liuzza and CFO Chris Moe, providing performance updates and ongoing initiatives.
Fiserv, Inc. announced that Hard Rock Stadium has adopted its Clover Sport platform as the official point-of-sale technology solution. The system includes over 1,000 Clover Station Duo terminals and handheld Clover Flex units to streamline transactions and operational management during diverse large-scale events. This marks an important expansion o…
AVAX One Technology Ltd. announced significant progress in improving its balance sheet during the third quarter of 2026, including elimination of more than $14.9 million in convertible debt and continued share repurchases. The company reduced its convertible debt balance to approximately $970,000 as of September 30, 2026, enhancing liquidity and fi…
Fusemachines Inc. has launched fuse.ai, a dedicated platform showcasing its innovative AI Twin technology aimed at extending individual presence and participation in workplace environments through AI. This initiative highlights the company's commitment to developing AI that operates on human values, addressing technical, ethical, and legal challeng…
BioNexus Gene Lab Corp. (Nasdaq: BGLC) announced a definitive agreement with Ruanyun Edai Technology Inc. (Nasdaq: RYET) granting BGLC an exclusive Malaysian healthcare license to RYET's CogniAI artificial intelligence platform. The platform will be used to develop AI applications supporting Malaysia's public healthcare digitalization program invol…
DeFi Development Corp., the first U.S. public company with a treasury focused on accumulating and compounding Solana (SOL), announced that its CEO and CSO will present at the 2026 Maxim Growth Summit. They will highlight the company's unique SOL treasury strategy and its Nasdaq-listed preferred stock CHAD as funding tools for growth. The company op…
Mint Incorporation Limited's subsidiary Axonex Robotics has signed a two-year OEM Supply and License Agreement with Ireland-based Centridex to provide robot kits and platform licenses. Centridex will assemble, test, and distribute finished robots in Ireland and selected European markets, marking Mint's strategic move to broaden its international fo…
Propanc Biopharma announced promising preclinical data for its lead candidate PRP, demonstrating over 90% tumor growth inhibition, reduced metastases, and tumor microenvironment remodeling in pancreatic ductal adenocarcinoma models. PRP offers a distinct mechanism from Revolution Medicines' FDA-approved daraxonrasib, targeting cancer pathways not a…
TOMI Environmental Solutions, trading on NASDAQ under TOMZ, confirmed its preparedness to support global biosecurity efforts through its disinfection technology and services. The company highlighted its capability to assist hospitals, laboratories, and government agencies in response to potential outbreaks, using its SteraMist systems. This announc…
RenovoRx has enrolled the first patient in the PRISM-TAMP investigator-initiated trial, evaluating neoadjuvant intra-arterial gemcitabine delivery via their TAMP platform for borderline resectable pancreatic ductal adenocarcinoma. This marks a clinical expansion beyond their ongoing Phase III for locally advanced pancreatic cancer, with results ant…
Alphabet trades at roughly 17x earnings with $53B of free cash flow and a fortress-like balance sheet. Short-term macro noise and AI capex headlines create entry points; we outline an actionable swing trade with defined entry, stop and target and explain the fundamental drivers and risks.
Progyny, Inc., a leader in women's health and family-building solutions, announced that its current annual selling season is pacing to a record level with an expected addition of 1.2 million new covered lives in the first half of 2027. The company's fertility solutions address rising medical cost inflation by offering employers programs that improv…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs and further its subsidiary CliniQuantum, announced a successful demonstration of a quantum-enabled GPU-accelerated platform that analyzed over 7 billion potential three-gene combinations in real-world clinical data. Utilizing a single NVIDIA T4 GPU, their platform achieved approxi…
Akita Drilling's purchase of Fox Drilling meaningfully expands its operational footprint in North America. The combination should drive higher utilization and revenue optionality; given a $147M market cap and depressed share price versus the 52-week high, there's a tradeable long with defined risk. This idea lays out entry, stop, targets, catalysts…
SeaStar Medical received FDA Breakthrough Device Designation for its Selective Cytopheretic Device (SCD) therapy to treat hyperinflammation in adult patients with sepsis or septic conditions. This designation accelerates development and review processes, marking the seventh breakthrough designation for the SCD platform across multiple indications. …
FuelCell Energy, Inc. announced a planned transition in its CFO position with Michael Bishop stepping down after 15 years and Matthew Latino succeeding him. The company reaffirmed its target to achieve positive Adjusted EBITDA in Q4 fiscal 2027, contingent on production increases and backlog conversion. FuelCell Energy is focused on scaling manufac…
MAIA Biotechnology announced completion of patient enrollment in Part C of its Phase 2 THIO-101 trial and achieving 65% enrollment in its pivotal Phase 3 THIO-104 trial investigating ateganosine combined with checkpoint inhibitors for treatment of advanced non-small cell lung cancer (NSCLC). Interim Phase 2 data show high disease control rates sign…
VivoSim Labs celebrates the FDA's updated regulations officially permitting the use of non-animal New Approach Methodologies (NAMs), including VivoSim's 3D human tissue models, for drug safety testing. This advancement potentially increases clinical trial success rates and reduces drug development costs by enabling earlier identification of toxic d…
ExlService Holdings, Inc., a global data and AI company, will release its financial results for the third quarter ended September 30, 2026, on October 27, after market close. The company will host a conference call on October 28 featuring executives discussing operational and financial outcomes. EXL serves multiple industries including insurance, h…
Safe Pro Group Inc., a U.S.-based AI-enabled defense and security solutions company, announced preliminary expectations of a 2,300% year-over-year revenue growth in Q3 2026, driven by multiple U.S. Army and Air Force subcontracts. The company's innovative AI threat detection and battlefield mapping technology is gaining traction with government age…
Skyworks Solutions announced that its Si829x isolated safety gate driver featuring ProVCD™ technology has completed AEC-Q100 automotive qualification and is now available for customer evaluation and prototyping. The device supports SiC FETs and IGBTs, targets scalable high-performance inverter architectures, and offers safety features suitable for …
Esperion Therapeutics has reached a settlement agreement with Renata Limited preventing the marketing of generic versions of its cholesterol-lowering drugs NEXLETOL and NEXLIZET in the US until April 19, 2040, reinforcing its patent protection. Ongoing litigations with other generic filers continue. Esperion, wholly owned by ARCHIMED, focuses on ca…
